Adam R Karpf

Roswell Park Cancer Institute Corp

$2,229,203

Attributed

$2,229,203

Total exposure

Grants

Lead (contact PI)

Attributed= this PI's even-split share of every grant they're on (the fair, additive number). Exposure = full size of all those grants. They are the sole PI on all grants (the two match).

Funding over time

peak $426.3K · FY2006–24

$500K$375K$250K$125K$0

'06

'07

'08

'09

'10

'11

'12

'13

'14

'15

'16

'17

'18

'19

'20

'21

'22

'23

'24

Funding mix

By agency

NIH$2,229,203 · 4

By mechanism

R01$1,398,986 · 1

R21$677,717 · 2

R03$152,500 · 1

Top collaborators

No co-investigators on record.

Others in their field

Top investigators on “Malignant Neoplasms”

David Heimbrook · Leidos Biomedical Research, Inc.$1,074,554,219
Leonard Freedman · Leidos Biomedical Research, Inc.$527,106,485
Ethan Dmitrovsky · Leidos Biomedical Research, Inc.$357,875,933
Richard K. Wilson · Washington University$274,272,747
Larry Arthur$223,443,122
Lynn Briscoe · Leidos Biomedical Research, Inc.$186,892,879

Research focus

Malignant NeoplasmsMalignant Neoplasm Of OvaryPlayDna MethylationDna Modification MethylasesGenomicsMolecularMediatingTumorigenesisEpigenetic ProcessGene ExpressionBaseCancer PatientInvestigationTumorIn VivoCancer CellGenomic InstabilityKnock-OutCell ModelEpithelial Ovarian CancerBiological ModelsEnzymesFuture